Jpmorgan Chase & CO Elanco Animal Health Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 10,057,656 shares of ELAN stock, worth $135 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,057,656
Previous 5,695,857
76.58%
Holding current value
$135 Million
Previous $82.2 Million
79.64%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ELAN
# of Institutions
437Shares Held
473MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$1.12 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$707 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$658 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$313 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$286 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.37B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...